ducovest

LABU:NYE-Direxion Daily S&P Biotech Bull 3X Shares (USD)

ETF | Trading--Leveraged Equity |

Last Closing

USD 96.24

Change

0.00 (0.00)%

Market Cap

USD 0.82B

Volume

0.76M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The fund, under normal circumstances, invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards (GICS). The fund is non-diversified.

Company Website : http://www.direxionfunds.com

Currency: USD

Country : USA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-25 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B..

N/A

 USD 9.92B
FNGU MicroSectors FANG+ Index 3X Le..

N/A

 USD 7.96B
QLD ProShares Ultra QQQ

N/A

 USD 7.84B
SSO ProShares Ultra S&P500

N/A

 USD 5.60B
UPRO ProShares UltraPro S&P500

N/A

 USD 4.27B
TECL Direxion Daily Technology Bull..

N/A

 USD 3.43B
YINN Direxion Daily FTSE China Bull..

N/A

 USD 1.61B
USD ProShares Ultra Semiconductors

N/A

 USD 1.16B
UDOW ProShares UltraPro Dow30

N/A

 USD 0.91B
DPST Direxion Daily Regional Banks ..

N/A

 USD 0.79B

ETFs Containing LABU

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -21.10% 9% A- 12% F
Dividend Return 0.25% 8% B- 2% F
Total Return -20.84% 8% B- 11% F
Trailing 12 Months  
Capital Gain -25.59% 9% A- 10% F
Dividend Return 0.24% 8% B- 2% F
Total Return -25.35% 7% C- 9% A-
Trailing 5 Years  
Capital Gain -91.89% 8% B- 2% F
Dividend Return 0.06% 2% F N/A F
Total Return -91.82% 8% B- 2% F
Average Annual (5 Year Horizon)  
Capital Gain 492.74% 97% N/A 99% N/A
Dividend Return 492.86% 97% N/A 99% N/A
Total Return 0.12% 9% A- 5% F
Risk Return Profile  
Volatility (Standard Deviation) 2,843.05% 4% F 1% F
Risk Adjusted Return 17.34% 30% F 33% F
Market Capitalization 0.82B 82% B 55% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.